DaVita (DVA) financials

Health Care Services · NYSE · Health Care

$187.50 -3.01% Close Oct 30, 2026 Live

DaVita revenue and earnings by year

DaVita's revenue was $13.6 billion in the fiscal year to December 31, 2025, up 6.5% from the year before. Net income was $747 million, 5.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 2.7% a year on average.

RevenueNet income
$5.00B$10.0B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue13.612.812.111.611.611.611.411.410.910.7
Revenue growth6.5%5.6%4.6%-0.1%0.6%1.4%-0.1%4.9%1.6%—
Gross profit4.44.23.83.43.63.63.53.23.23.3
Gross margin32.2%32.9%31.5%29.3%31.4%30.8%30.5%28.1%29.8%30.6%
Operating income2.02.11.61.31.81.71.61.51.82.0
Operating margin14.7%16.1%13.0%11.3%15.2%14.4%14.3%13.4%16.7%18.8%
Net income0.70.90.70.61.00.80.80.20.70.9
Net margin5.5%7.3%5.7%4.8%8.4%6.7%7.1%1.4%6.1%8.2%
Diluted EPS$9.84$10.73$7.42$5.85$8.90$6.29$5.37$0.79$3.46$4.29
Free cash flow1.31.51.51.01.31.31.30.81.01.1

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DVA in Markets.

How DaVita makes money

Revenue by segment in the quarter to September 30, 2026, as the company reports it.

SegmentRevenueShare
U S Dialysis & Related Lab Services$3.03B84.6%
Other Operating Segments With Intersegment$552M15.4%

See also: DVA valuation and P/E history · DVA returns

No forecast, no recommendation. This page describes DaVita from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.